ArticleInternational journal of molecular medicine2019

Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-κB, blocking the TLR4 pathway and reducing ROS generation.

Shin Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.